Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • toots
    Junior Member
    • Oct 2012
    • 2

    Plotting distribution of allelic frequency under different coverage values

    I'm new to bioinformatics, and have an incomprehensible PI. Could someone clue me in on some of what is going on in the prompt below? For instance:
    1) What's "LD"?
    2) What do the different coverage values signify? How do I implement that in R?
    3) I have no idea what the RefAlleleCount, etc. bit means. Aren't all of those ratios the same anyhow?

    I realize I'm asking really broad, noobish questions, but a little context would be reeeaaally helpful. Thanks.

    " RNAseq reads covered 5,000 biallelic human autosomal SNPs (all are heterogeneous, assume they are not in LD). Please write simple R statements to plot the distribution of the alternative allelic frequency under sequencing coverage 2x, 5x, 10x, 20x, respectively. Also calculate the p-values with the hypothesis that there are no differential allelic expression for these three SNPs: (RefAlleleCount:AltAlleleCount) 1:4, 2:8, 4:16. "

    Edit: I've discovered that LD is linkage disequilibrium. Still fairly lost though.
    Last edited by toots; 10-22-2012, 08:36 AM.
  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #2
    1) LD = Linkage Disequalibrium
    2) Coverage refers to the number of reads covering each bp
    3) RefAlleleCount = # of reads with the reference allele, AltAlleleCount = # reads with an alternative allele (i.e. not matching the reference).

    Comment

    • toots
      Junior Member
      • Oct 2012
      • 2

      #3
      Is there actually enough information in that prompt to do an analysis in R? I don't even know which "three SNPs" are being referred to. Is that implicit somehow?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      217 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      81 views
      0 reactions
      Last Post SEQadmin2  
      Working...